Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction

Heart failure with preserved ejection fraction (HFpEF) is the presence of clinical signs and/or symptoms of heart failure with a left ventricular ejection fraction (LVEF) ≥50%. Risk factors associated with this disease include hypertension, hyperlipidemia, atrial fibrillation (AF), obesity, diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Paz, Pablo Alejandro, Mantilla, Barbara Daniela, Argueta, Erwin E., Mukherjee, Debabrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review article on Heart Failure Update and Advances in 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039660/
https://www.ncbi.nlm.nih.gov/pubmed/33850920
http://dx.doi.org/10.21037/atm-20-4602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039660/
https://www.ncbi.nlm.nih.gov/pubmed/33850920
http://dx.doi.org/10.21037/atm-20-4602

Ejemplares similares